04/10/2024
12:06 PM | Karas Douglas John (Reporting)
Nascent Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
12:06 PM | Carrick Sean (Reporting)
Nascent Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
12:07 PM | HOLDEN LOWELL THOMAS (Reporting)
Nascent Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
11:15 PM | Nascent Biotech (Filer)
| Form EFFECT | |
03/29/2024
1:53 PM | Nascent Biotech (Filer)
| Form S-1/A | |
03/14/2024
8:14 PM | Nascent Biotech (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
02/27/2024
12:45 PM | Karas Douglas John (Reporting)
Nascent Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
12:46 PM | HOLDEN LOWELL THOMAS (Reporting)
Nascent Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
12:46 PM | Carrick Sean (Reporting)
Nascent Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
7:00 AM | Nascent Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
1:22 PM | Nascent Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
1:22 PM | Karas Douglas John (Reporting)
Nascent Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
1:47 PM | Nascent Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/06/2023
12:54 PM | Nascent Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/18/2023
4:00 PM | Nascent Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/14/2023
1:37 PM | Nascent Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2023
7:42 AM | Carrick Sean (Reporting)
Nascent Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
10:26 AM | HOLDEN LOWELL THOMAS (Reporting)
Nascent Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:15 PM | Nascent Biotech (Filer)
| Form 10-K/A | |
06/29/2023
11:26 AM | Nascent Biotech (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
06/09/2023
2:27 PM | Carrick Sean (Reporting)
Nascent Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
2:28 PM | HOLDEN LOWELL THOMAS (Reporting)
Nascent Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
2:28 PM | Karas Douglas John (Reporting)
Nascent Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2023
7:00 AM | Nascent Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
